
Spain is investigating the drugmaker Novo Nordisk over concerns that it may be illegally advertising its blockbuster weight loss drugs Ozempic and Wegovy.
It is the latest in a string of inquiries into the Danish pharmaceutical giant, with authorities in at least two other European countries accusing Novo Nordisk of unlawfully promoting its medications in recent years.